摘要:
The present invention refers to a method of incorporating non-genetically encoded amino acids at single or multiple positions of a protein and optionally the further modification of the side chains of said non-genetically encoded amino acids, e.g. by introduction of glycan groups. Further, the present invention refers to novel single or multiple glycosylated proteins.
摘要:
The present application relates to new heteroaryl-substituted dicyanopyridines having formula (I), to a method for the production thereof, to the use thereof for treatment and/or prevention of diseases and also the use thereof for production of pharmaceuticals for treatment and/or prevention of diseases, preferably for treatment and/or prevention of cardiovascular diseases.
摘要:
A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific markers in body fluids (e.g. CSF), using mass spectrometric analysis (SELDI-TOF MS). The specific markers are: human cystatin C, human beta-2-microglobulin, human myoglobin neurosecretory protein VGF or fragments of these proteins.
摘要:
The present invention relates to a method for the production of onolytic adenoviruses having increased potency and their therapeutic applications for cancer. Recombinant adenoviruses and methods to produce them are provided.
摘要:
The invention provides PRSS23 which is associated with the cardiovascular diseases, hematological diseases, neurological diseases, respiratory diseases, gastroenterological diseases and urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, hematological diseases, neurological diseases, respiratory diseases, gastroenterological diseases and urological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of PRSS23 as well as pharmaceutical compositions comprising such compounds. The invention also provides PRSS23 as a biomarker for diseases as cardiovascular diseases, hematological diseases, neurological diseases, respiratory diseases, gastroenterological diseases and urological diseases.
摘要:
The invention provides CTGF which is associated with the cardiovascular diseases and hematological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases and hematological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of CTGF as well as pharmaceutical compositions comprising such compounds. The invention also provides CTGF as a biomarker for diseases as cardiovascular diseases and hematological diseases
摘要:
The present invention relates to novel compounds suitable for or already radiolabeled with 18F, methods of making such compounds and use of such compounds for diagnostic imaging. Such labeled vompounds are characerized by Formula II, wherein the moieties F, R1, R2, B1,2, Y1.2,, Z1.2 and E have the meaning as defined in the specification and claims.
摘要:
Die vorliegende Erfindung betrifft nichtsteroidale Progesteronrezeptor-Modulatoren der allgemeinen Formel I,
die Verwendung der Progesteronrezeptor-Modulatoren zur Herstellung von Arzneimitteln sowie pharmazeutische Zusammensetzungen, die diese Verbindungen enthalten. Die erfindungsgemäßen Verbindungen sind geeignet zur Therapie und Prophylaxe von gynäkologischen Erkrankungen wie Endometriose, Leiomyomen des Uterus, dysfunktionelle Blutungen und Dysmenorrhoe sowie für die Therapie und Prophylaxe von hormonabhängigen Tumoren und zur Verwendung für die weibliche Fertilitätskontrolle sowie für die Hormonersatztherapie.
摘要:
The present invention relates to (het)aryl-3-[(het)arylpiperidin-4-yl]amides, to processes for their preparation and to their use for producing pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.